 VANCOUVER, British Columbia, June 15, 2021 GLOBE NEWSWIRE -- BetterLife Pharma Inc. BetterLife or the Company CSE: BETR OTCQB: BETRF FRA: NPAU , an emerging biotech company focused on non-hallucinogenic psychedelic therapeutics, today announced that Ahmad Doroudian, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021. 